Today: 9 April 2026
Subscribe
Browse Category

NYSE:BSX 22 October 2025 - 25 December 2025

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific shares traded at $95.76, down 0.36% as of 17:30 UTC Friday, after opening at $96.85 and moving between $95.64 and $97.24. The session coincided with December options expiration, with $7.1 trillion in contracts set to expire. UBS reiterated a Buy rating and $140 target, while Truist cut its target to $120. Trading volume Thursday reached 15.6 million shares, well above the 50-day average.
19 December 2025
·
Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific closed Thursday at $96.11, up 1.73%, with trading volume of 15.6 million shares, well above its 50-day average. After-hours trading was steady, with shares at $96.18 as of 6 p.m. ET. Truist Securities lowered its price target to $120 from $130 but kept a Buy rating. The stock remains 12.23% below its 52-week high of $109.50.
19 December 2025
·
Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific shares closed up 1.65% at $94.48 on Wednesday, outperforming the broader market as the S&P 500 fell 1.16%. The stock traded as high as $95.99 intraday and saw volume above its 50-day average. After-hours, BSX edged up to $94.70. The stock remains about 13.7% below its 52-week high set in September.
18 December 2025
·
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

UBS reiterated a Buy rating on Boston Scientific, keeping its $140 price target and citing upside potential into 2026. RBC raised its target to $130, while Canaccord Genuity adjusted to $131. BSX shares opened near $92.93, down about 10% in a month, with a market cap around $138 billion. Analysts point to growth in cardiac devices but warn on valuation and policy risks.
17 December 2025
·
Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific shares closed at $92.53 on December 9, down 1.4% and marking a seventh straight decline, with trading volume spiking to 12.7 million shares. The stock sits about 15% below its September high despite strong Q3 results, including 20% year-over-year sales growth and adjusted EPS of $0.75, beating forecasts. Over the past year, BSX remains slightly positive and is up about 170% over five years.
10 December 2025
··
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific (BSX) closed at $98.57 on December 3, down slightly, with shares trading in a $97.60–$99.30 range. EVP Arthur Butcher sold 17,313 shares on December 1 for about $1.76 million under a pre-arranged plan. The stock is up roughly 8–9% over the past year but remains about 9.6% below its September high. The company also received new European device approvals this week.
4 December 2025
·
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific shares fell 2.6% to $96.60 in late trading Wednesday, extending a three-day slide despite new research highlighting neuromodulation growth and recent acquisitions. The stock remains in the upper half of its 52-week range, with a market cap near $145–150 billion and trading at about 53 times trailing earnings.
19 November 2025
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

U.S. stock indexes hover near record highs after the Dow gained 0.5% Tuesday, while the Nasdaq slipped 0.2% on tech earnings misses. About 85% of S&P 500 companies have beaten forecasts, the highest rate in four years. AMD surged to record highs on AI chip deals, while Eli Lilly hit $935 on obesity drug demand. Netflix fell 6–7% pre-market after an earnings miss; Texas Instruments dropped nearly 9% on weak guidance.
22 October 2025
···········
1 2

Stock Market Today

  • Stocks Slip as US-Iran Ceasefire Optimism Wanes; Oil Prices Surge
    April 9, 2026, 12:18 PM EDT. Stocks dipped as S&P 500, Dow Jones, and Nasdaq 100 indexes retreated following fading optimism over a US-Iran ceasefire. June E-mini futures reflected this softening trend. Crude oil jumped over 5%, driven by the Strait of Hormuz blockade and escalating tensions from Israeli-Lebanon clashes, threatening the fragile truce. Both the US and Iran accused each other of ceasefire breaches, complicating Saturday's talks. U.S. economic data disappointed, with rising unemployment claims, weaker personal income and spending, and downwardly revised Q4 GDP growth adding pressure. Oil tanker restrictions amplified shipping delays, with over 1,000 vessels waiting near the strait, historically a key global energy transit route. Markets price in only a 2% chance of a Federal Reserve rate hike in late April, while overseas shares also fell, weighing on sentiment.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Go toTop